%0 Journal Article
%B JAMA Dermatol
%D 2023
%G eng
%M 37285130
%R 10.1001/jamadermatol.2023.1400
%T Fertility Trends and Adverse Pregnancy Outcomes in Female Patients With Psoriasis in the UK
%2 PMC10248813 Almirall, Celgene, Eli Lilly, Galderma, GSK, Leo Pharma, Janssen, Novartis, Pfizer, and UCB Pharma; grants from Almirall, Amgen, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, and UCB Pharma; and nonfinancial support from Eli Lilly, Leo Pharma, Janssen, and UCB Pharma outside the submitted work. Prof Griffiths reported grants from the LEO Foundation and the International League of Dermatological Societies during the conduct of the study, as well as grants from Almirall and UCB Pharma and personal fees from AbbVie, Boehringer Ingelheim, Evelo Bioscience, Inmagene, Eli Lilly, Janssen, Novartis, GSK, Ono Pharmaceutical, and Bristol Myers Squibb outside the submitted work. Prof Ashcroft reported grants from Abbvie, Almirall, Celgene, Eli Lilly, Janssen, Novartis, UCB Pharma and the LEO Foundation during the conduct of the study. No other disclosures were reported.
%7 2023/06/07
%@ 2168-6068 (Print)
2168-6068